Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series D brings in $21mm for InfraReDx

Executive Summary

InfraReDx Inc. (cardiovascular diagnostic imaging technologies) has raised $21mm through its Series D venture round. Current shareholder Sanderling Ventures led the financing and was joined by new institutional investors, including GMP Securities. The company will use the proceeds for the commercial launch of its LipiScan IVUS coronary imaging system, which recently gained US approval as a tool to identify and characterize plaque in the coronary arteries.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies